Hainan Lingkang Pharmaceutical Co., Ltd. | Pharmaceutical Manufacturer Profile & Drug Portfolio Page 31

The main ingredient of this product is clindamycin phosphate

Name	Description	Content	CAS NO.	Registered Holders
Clindamycin phosphate	Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci (such as Staphylococcus aureus and Staphylococcus epidermidis, Streptococcus, and Pneumococcus), anaerobic Gram-negative rods (such as Bacteroides and Fusobacterium), anaerobic Gram-positive non-spore-forming rods (such as Propionibacterium, Eubacterium, and Actinomyces), and anaerobic and microaerophilic Gram-positive rods (such as Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus). More Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci (such as Staphylococcus aureus and Staphylococcus epidermidis, Streptococcus, and Pneumococcus), anaerobic Gram-negative rods (such as Bacteroides and Fusobacterium), anaerobic Gram-positive non-spore-forming rods (such as Propionibacterium, Eubacterium, and Actinomyces), and anaerobic and microaerophilic Gram-positive rods (such as Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus).		24729-96-2	33

Clindamycin Phosphate for Injection

The main ingredient of this product is clindamycin phosphate

Name	Description	Content	CAS NO.	Registered Holders
Clindamycin phosphate	Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, and Pneumococcus), anaerobic Gram-negative rods (such as Bacteroides and Fusobacterium), anaerobic Gram-positive non-spore-forming rods (such as Propionibacterium, Eubacterium, and Actinomyces), and anaerobic and microaerophilic Gram-positive rods (such as Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus). More Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, and Pneumococcus), anaerobic Gram-negative rods (such as Bacteroides and Fusobacterium), anaerobic Gram-positive non-spore-forming rods (such as Propionibacterium, Eubacterium, and Actinomyces), and anaerobic and microaerophilic Gram-positive rods (such as Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus).		24729-96-2	33

Clindamycin Phosphate for Injection

The main ingredient of this product is clindamycin phosphate

Name	Description	Content	CAS NO.	Registered Holders
Clindamycin phosphate	Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci, anaerobic Gram-negative bacilli, anaerobic Gram-positive non-spore-forming Bacillus, and anaerobic and microaerophilic Gram-positive bacilli. More Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci, anaerobic Gram-negative bacilli, anaerobic Gram-positive non-spore-forming Bacillus, and anaerobic and microaerophilic Gram-positive bacilli.		24729-96-2	33

Cefmenoxime Hydrochloride for Injection

The abbreviation of the active ingredient of this drug is CMX, the molecular formula is C16H17N9O5S3·1/2HCl, and the molecular weight is 529.78. Melting point: It starts to turn yellow at about 130℃, then slowly turns brown, and carbonizes at about 190℃. There is no clear melting point or decomposition point.

Name	Description	Content	CAS NO.	Registered Holders
CMX (cephalosporin hydrochloride)	It inhibits the synthesis of bacterial cell wall, has good permeability to the cell wall, is stable to β-lactamase, has a strong affinity for penicillin-binding proteins 1A, 1B and 3, and can strongly inhibit the cross-linking of cell wall mucopeptides. More It inhibits the synthesis of bacterial cell wall, has good permeability to the cell wall, is stable to β-lactamase, has a strong affinity for penicillin-binding proteins 1A, 1B and 3, and can strongly inhibit the cross-linking of cell wall mucopeptides.			0

Cefmenoxime Hydrochloride for Injection

The abbreviation of the active ingredient of this drug is CMX, the molecular formula is C16H17N9O5S3·1/2HCl, and the molecular weight is 529.78. Melting point: It starts to turn yellow at about 130℃, then slowly turns brown, and carbonizes at about 190℃. There is no clear melting point or decomposition point.

Name	Description	Content	CAS NO.	Registered Holders
CMX (cephalosporin hydrochloride)	It inhibits the synthesis of bacterial cell wall, has good permeability to the cell wall, is stable to β-lactamase, has a strong affinity for penicillin-binding proteins 1A, 1B and 3, and can strongly inhibit the cross-linking of cell wall mucopeptides. More It inhibits the synthesis of bacterial cell wall, has good permeability to the cell wall, is stable to β-lactamase, has a strong affinity for penicillin-binding proteins 1A, 1B and 3, and can strongly inhibit the cross-linking of cell wall mucopeptides.			0